Epidemiology of drug-resistant malaria in Republic of Congo: Using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use

Tropical Medicine and International Health

Volumn 10, Issue 10, 2005, Pages 1030-1037

  Nsimba, Basile ^a   Jafari Guemouri, Sayeh ^b   Malonga, David A ^c   Mouata, André M ^d   Kiori, Jeannine ^d   Louya, Frédéric ^a   Yocka, Dominique ^e   Malanda, Maurice ^c   Durand, Rémy ^b   Le Bras, Jacques ^b  

^a Ministry of Health   (Congo)

^b BICHAT HOSPITAL   (France)

^c Department of Pediatrics   (Congo)

^d Tié Tié Hospital   (Congo)

^e Jane Vialle Health Centre   (Congo)

Author keywords

Antimalarial drugs; Congo; Drug policy; Drug resistance; Genotypes; Malaria

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; DIHYDROFOLIC ACID; DIHYDROPTEROATE SYNTHASE; FANSIDAR; MALOPRIM; MOLECULAR MARKER; QUININE;

DRUG DEVELOPMENT; EPIDEMIOLOGICAL PHENOMENA; MALARIA;

ARTICLE; CONGO; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; GENE MUTATION; GENOTYPE; HUMAN; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTOZOAL GENETICS; TREATMENT FAILURE; URINALYSIS;

ANTIMALARIALS; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; CHLOROQUINE; CONGO; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MUTATION; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; TREATMENT OUTCOME; URBAN HEALTH;

AFRICA; CENTRAL AFRICA; CONGO; EASTERN HEMISPHERE; SUB-SAHARAN AFRICA; WORLD;

PLASMODIUM FALCIPARUM;

EID: 26844518733     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01490.x     Document Type: Article

References (29)

1. Aubouy A, Jafari S, Huart V et al. (2003a) DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine/pyrimethamine treatment efficacy. Journal of Antimicrobial Chemotherapy 52, 43-49.
2. Aubouy A, Bakary M, Keundjian A et al. (2003b) Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrobial Agents Chemotherapy 47, 231-237.
3. Babiker HA, Pringle SJ, Abdel-Muhsin A et al. (2001) High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Journal of Infectious Diseases 183, 1535-1538.
4. Basco LK, Tahar R, Keundjian A & Ringwald P (2000) Sequence variations in the genes encoding dihydropteroate synthetase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. Journal of Infectious Diseases 182, 624-628.
5. Bwijo B, Kaneko A, Takechi M et al. (2003) High prevalence of quintuple mutant dhps/dhfr genes in introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Tropica 85, 363-373.
6. Djimdé A, Doumbo OK, Cortese JF et al. (2001) A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine 344, 257-263.
7. Djimdé A, Dolo A, Ouattara A et al. (2004) Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. Journal of Infectious Diseases 190, 853-855.
8. Dorsey G, Kamya MR, Singh A & Rosenthal PJ. (2001) Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. Journal of Infectious Diseases 183, 1417-1420.
9. Durand R, Jafari S, Vauzelle J et al. (2001) Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of P. falciparum. Molecular and biochemical parasitology 114, 95-102.
10. Ekundzola JR (1990) AIDS in the Congo. Vie Santé 5, 28-29.
11. Kublin JG, Dzinjalamala FK, Kamwendo DD et al. (2002) Molecular markers for failure of sulfadoxine/pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases 185, 380-388.
12. Kublin JG, Cortese JF, Mbindo Njunju E et al. (2003) Re-emergence of chloroquine-sensitive Plasmodium falciparum Malaria after cessation of chloroquine use in Malawi. Journal of Infectious Diseases 187, 1870-1875.
13. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ & Dorsey G (2003) Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum Malaria. American Journal of Tropical Medicine and Hygiene 69, 247-252.
14. Lyer JK, Milhous WK, Cortese JF, Kublin JG & Plowe CV (2001) Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. The Lancet 358, 1066-1067.
15. Mayor AG, Gomez-Olivé X, Aponte JJ et al. (2001) Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. Journal of Infectious Diseases 183, 1413-1416.
16. Mita T, Kaneko A, Lum JK et al. (2003) Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. American Journal of Tropical Medicine and Hygiene 68, 413-415.
17. Mount DL, Nahlen BL, Patchen LC & Churchill FC (1989) Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bulletin of the World Health Organization 67, 295-300.
18. Nsimba B, Malonga DA, Mouata AM et al. (2004) Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. American Journal of Tropical Medicine and Hygiene 70, 133-138.
19. Pictet G, Le Cœur S, M'Pele P, Brouard N & Lallemant M (1998) Contribution of AIDS to the general mortality in central Africa: evidence from a morgue-based study in Brazzaville, Congo. AIDS 12, 2217-2223.
20. Plowe CV, Djimdé A, Bouare M, Doumbo OK & Wellems TE (1995) Pyrimethamine and Proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565-568.
21. Ringwald P, Keundjian A, Same Ekobo A & Basco LK (2000) Chimiorésistance de P. falciparum en milieu urbain à Yaoundé, Cameroun. Part2: evaluation de l'efficacité de l'amodiaquine et de l'association sulfadoxine-pyriméthamine pour le traitement de l'accès palustre simple à Plasmodium falciparum à Yaoundé, Cameroun. Tropical Medicine and International Health 5, 620-627.
22. Roper C, Pearce R, Bredenkamp B et al. (2004) Antifolate antimalarial resistance in southeast Africa: a population-based analysis. The Lancet 361, 1174-1181.
23. Talani P, Samba G & Moyen G (2003) Management of children's fever at home in a rural area of Boko (Congo-Brazzaville). Sante Publique 15, 485-490.
24. Talisuna AO, Kyosiimire-Lugemwa J, Langi P et al. (2002) Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine CQ-resistant Plasmodium falciparum malaria in Uganda sentinel sites with high CQ resistance. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 551-556.
25. Talisuna AO, Bloland P & D'Alessandro U (2004) History, dynamics, and public health importance of malaria parasite resistance. Clinical Microbiology Reviews 17, 235-254.
26. Vinayak S, Biswas S, Dev V et al. (2003) Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Tropica 87, 287-293.
27. World Health Organization (WHO) (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission (WHO/MAL/96.1077). WHO, Geneva, Switzerland.
28. World Health Organization (WHO) (2000) Malaria. World Health Organization, Technical Report Series 892, Geneva.
29. World Health Organization (WHO) and the joint United Nations Programme on HIV/AIDS (UNAIDS) (2001) Provisional WHO/UNAIDS secretariat. Recommendations on the use of co-trimoxazole prophylaxis in adults, and children living with HIV/AIDS in Africa, available at: http://www.unaids.org/publications/documents/ care/general/recommendation-eng.pdf (accessed on 17 September 2001).